Michael Joseph Hansbury

Title: Michael Joseph Hansbury: Innovator in Proliferative Disease Treatments

Introduction

Michael Joseph Hansbury is a notable inventor based in Collingswood, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments for proliferative diseases. With a total of 6 patents to his name, Hansbury's work has the potential to impact various medical conditions.

Latest Patents

One of Hansbury's latest patents is focused on the Human Pelota homolog - 68772 polypeptides and polynucleotides. This patent discloses methods for producing such polypeptides by recombinant techniques. Additionally, it outlines methods for utilizing these polypeptides and polynucleotides in designing protocols for treating proliferative diseases, including leukemias, solid tumor cancers, and metastases. The patent also addresses chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis, as well as proliferative cardiovascular diseases like restenosis. Furthermore, it covers proliferative ocular disorders such as diabetic retinopathy and benign hyperproliferative diseases like hemangiomas, along with diagnostic assays for these conditions.

Career Highlights

Throughout his career, Hansbury has worked with prominent organizations, including SmithKline Beecham Corporation. His experience in these companies has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Some of Hansbury's notable coworkers include Jeffrey Richard Jackson and Sandhya S Nerurkar. Their collaborations have likely played a role in advancing research and development in their respective fields.

Conclusion

Michael Joseph Hansbury is a distinguished inventor whose work in biotechnology has the potential to revolutionize treatments for various proliferative diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.